OpenFilings

Whitehawk Therapeutics, Inc.

Form10-K

Report Period2022-12-31

Date Filed2023-03-29

Time Filed17:34:21

Document Analysis

Natural Language Processing

Recognized Type Unidentified

Defined Term Format

Exhibits

10-K
EX-4.1
EX-10.4 - AMENDED AND RESTATED EXECUTIVE AGREEMENT, NEIL DESAI
EX-10.17
EX-10.21
EX-15.15 - BRE SUNSET COAST LLC, OFFICE LEASE
EX-21.1 - SUBSIDIARIES
EX-23.1
EX-31 - CEO/CFO SECTION 302
EX-32 - CEO/CFO SECTION 906
Filing on SEC Edgar